June 8, 2015.
Looking at aggregated data from The New York Times, which used filings from the Securities and Exchange Commission to compute CEO compensation, The Motley Fool, noting that four of the highest-paid CEOs in pharma saw their pay increase last year.
Motley Fool lists the five best-paid pharma CEOs as
The key question, the reports asks, is "Are these pay package increases merited?"
Can Data and AI Deliver Whole-Person Health?
July 9th 2024Executives in the life sciences and medical device industries see promise in artificial intelligence (AI) and medical technologies, but must also navigate the changing healthcare ecosystem, varied stakeholder needs, and the impact of AI on market access and commercialization strategies.